LPL Financial LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$132,233
-34.6%
18,677
-34.9%
0.00%
Q2 2023$202,118
-11.5%
28,710
+4.9%
0.00%
Q1 2023$228,299
-18.2%
27,374
+12.6%
0.00%
Q4 2022$279,021
+0.4%
24,305
+10.1%
0.00%
Q3 2022$278,000
+23.6%
22,077
+3.8%
0.00%
Q2 2022$225,000
-49.3%
21,259
-22.2%
0.00%
Q1 2022$444,000
+29.1%
27,334
+9.9%
0.00%
Q4 2021$344,000
-62.3%
24,870
-60.8%
0.00%
-100.0%
Q3 2021$912,000
-26.2%
63,465
-18.8%
0.00%0.0%
Q2 2021$1,235,000
+187.2%
78,118
+84.6%
0.00%
Q1 2021$430,000
+198.6%
42,307
+118.4%
0.00%
Q4 2020$144,000
+114.9%
19,369
-0.4%
0.00%
Q3 2020$67,000
-46.0%
19,439
-40.6%
0.00%
Q2 2019$124,000
-56.2%
32,733
-5.8%
0.00%
-100.0%
Q1 2019$283,000
+6.0%
34,733
+4.8%
0.00%0.0%
Q4 2018$267,000
+0.4%
33,133
-5.0%
0.00%0.0%
Q3 2018$266,000
+29.1%
34,883
-2.8%
0.00%0.0%
Q2 2018$206,000
+31.2%
35,883
+8.8%
0.00%
Q1 2018$157,000
-7.6%
32,983
-4.8%
0.00%
-100.0%
Q4 2017$170,00034,6580.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders